Moderna
MRNA
#705
Rank
โ‚น2.350 T
Marketcap
โ‚น6,115
Share price
-0.75%
Change (1 day)
-32.13%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: โ‚น2.350 Trillion

As of September 2024 Moderna has a market cap of โ‚น2.350 Trillion. This makes Moderna the world's 705th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2024

End of year Market Cap

Year Market cap Change
2024โ‚น2.350 T-25.54%
2023โ‚น3.156 T-44.72%
2022โ‚น5.710 T-25.59%
2021โ‚น7.674 T154.25%
2020โ‚น3.018 T544.17%
2019โ‚น468.55 B34.16%
2018โ‚น349.24 B

End of Day market cap according to different sources

On Sep 6th, 2024 the market cap of Moderna was reported to be:

โ‚น2.350 Trillion
by Yahoo Finance info icon info icon
โ‚น2.350 Trillion
by CompaniesMarketCap info icon info icon
โ‚น2.350 Trillion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
โ‚น8.62 B-99.63%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น25.059 T 966.08%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น69.9 M-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น2.657 T 13.07%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น19.881 T 745.81%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
โ‚น231.73 B-90.14%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น33.197 T 1,312.28%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น249.81 B-89.37%๐Ÿ‡บ๐Ÿ‡ธ USA